drugset / Trial / NCT02175381
Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The investigators propose to study the safety and efficacy of the combination of Carboplatin plus Gemcitabine in a Phase I/II trial of elderly subjects with non-small cell lung cancer.
Timeline
- Start
- 2011-02
- Primary completion
- 2014-04
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | 2.5 unknown | Intravenous |
| Subject | Gemcitabine | Small molecule | 1100 mg/m2 | Intravenous |